ѻýҕl

<ѻýҕl class="page-title">Clinical Challenges

ASH: DLBCL and CLL

<ѻýҕl class="page-description">American Society of Hematology

More in ASH: DLBCL and CLL

Clinical Challenges: Treating CLL When BTK Inhibition Fails

Strategies for patients who progress and those intolerant of ibrutinib

Dec 11, 2018
image